Clinical Trials Browser

Phase 1 × Leiomyosarcoma × Trabectedin × Clear all

NCT03437070 2019-03-18

Trabectedin, Doxorubicin and Olaratumab in Patients With Metastatic or Recurrent Leiomyosarcoma

Phase 1 Withdrawn

Leiomyosarcoma

NCT01426633 2014-12-16

Combination Therapy of Gemcitabine and Trabectedin in L-sarcomas

Phase 1 Completed

Leiomyosarcoma, Liposarcoma